ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹625 Cr | ₹604 Cr | ₹512 Cr | ₹475 Cr | ₹405 Cr |
What is the latest Total Liabilities ratio of ALBERT DAVID ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹625 Cr |
| Mar2024 | ₹604 Cr |
| Mar2023 | ₹512 Cr |
| Mar2022 | ₹475 Cr |
| Mar2021 | ₹405 Cr |
How is Total Liabilities of ALBERT DAVID Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹625 Cr | 3.34 | |
| Mar2024 | ₹604 Cr | 17.98 | |
| Mar2023 | ₹512 Cr | 7.82 | |
| Mar2022 | ₹475 Cr | 17.24 | |
| Mar2021 | ₹405 Cr | - | |
Compare Total Liabilities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹423.1 Cr | -1.3% | -7.7% | -46.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.9% | -1.8% | -2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | 2.1% | 0.2% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,619.0 Cr | 0.5% | 2.2% | 11.2% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | 0.7% | -0.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,741.0 Cr | -0.1% | 2.5% | 2.5% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -1.3% |
-7.7% |
-46.8% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses